Collaborations‎ > ‎

Breonics Inc.

BREONICS, Inc. founded in 1996 is a development stage biomedical research and discovery company developing innovative products for the clinical organ transplantation and tissue replacement markets. BREONICS' primary focus is on two of the major problems facing clinical transplantation today: the chronic shortage of organs and the adverse effects of systemic immuno-suppression.BREONICS intends to focus its resources on first developing its Exsanguineous Metabolic Support System (EMS) to significantly alleviate the shortage of kidneys available for transplantation into a clinical reality. The Company intends to provide to the Organ Procurement Organizations (OPOs) the materials and expertise to expand organ donation into the immense potential human donor pool that because of the limitations of present day technology are never considered.

Breonics website is: